BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7878990)

  • 1. Macrophages and nitric oxide are involved in primary nonfunction of islet xenografts.
    Marquet RL; Bonthuis F; Duval SY; de Bruin RW; van Rooijen N; Scheringa M; IJzermans JN
    Transplant Proc; 1995 Feb; 27(1):252-3. PubMed ID: 7878990
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide generation following intrahepatic human-to-rat islet transplantation is blocked by NG-monomethyl-L-arginine.
    Behboo R; Lancaster JR; Sweetland M; Korbanic C; Hoffman R; Simmons RL; Ricordi C
    Transplant Proc; 1994 Apr; 26(2):776. PubMed ID: 8171659
    [No Abstract]   [Full Text] [Related]  

  • 3. Local immunologic factors determine the occurrence of primary nonfunction of islet xenografts.
    Marquet RL; Bouwman E; Bonthuis F; Wolvekamp MC; Kouwenhoven E; van Rooijen N; Scheringa M; Ijzermans JN
    Transplant Proc; 1994 Apr; 26(2):766-7. PubMed ID: 8171654
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary nonfunction of islet xenografts: the role of macrophages.
    Marquet RL; Bonthuis F; van IJken M; Bouwman E; Wolvekamp MC; van Rooijen N; Scheringa M; IJzermans JN
    Transpl Int; 1994; 7 Suppl 1():S660-2. PubMed ID: 11271333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet xenografts in mice and rats: II. Mixed islet-spleen cell assay to analyze nitric oxide production and inhibition in xenogeneic species combinations.
    Jahr H; Nicolae M; Braun K; Ketchum R; Koeberlein B; Barker CF; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):775. PubMed ID: 8171658
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of nitric oxide in the pathogenesis of early pancreatic islet dysfunction during rat and human intraportal islet transplantation.
    Stevens RB; Lokeh A; Ansite JD; Field MJ; Gores PF; Sutherland DE
    Transplant Proc; 1994 Apr; 26(2):692. PubMed ID: 7513466
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary nonfunction of islet xenografts in rat recipients results from non-T-cell-mediated immune responses.
    Deng S; Ketchum RJ; Kucher T; Weber M; Naji A; Brayman KL
    Transplant Proc; 1997 May; 29(3):1726-7. PubMed ID: 9142249
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathymic transplantation promotes survival of islet xenografts (rat-->mouse).
    Mayo GL; Posselt AM; Campos L; Noorchashm N; Barker CF; Naji A
    Transplant Proc; 1994 Apr; 26(2):758. PubMed ID: 8171649
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary nonfunction of human pancreatic islet xenografts is murine strain dependent.
    Carty SE; Carroll PB; Rilo H; Brumfield A; Ricordi C
    Transplant Proc; 1994 Apr; 26(2):780. PubMed ID: 8171660
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse).
    Zeng Y; Bluestone JA; Ildstad ST; Torres MA; Montag AG; Thistlethwaite RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):438-9. PubMed ID: 8438368
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of primary nonfunction in discordant pancreas islet xenografts.
    Pittman K; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):649-50. PubMed ID: 1566465
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitric oxide production increases with intraportal islet xenograft transplantation.
    Behboo R; Lancaster JR; Nussler AK; Korbanic C; Rao AS; Ricordi C
    Transplant Proc; 1994 Dec; 26(6):3448. PubMed ID: 7998215
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of NG-monomethyl-L-arginine in a marginal renal subcapsular mouse islet transplant model.
    Ansite JD; Stevens RB; Lokeh A; Brown RR; Saxena M; Mills CD; Sutherland DE
    Transplant Proc; 1995 Feb; 27(1):605-6. PubMed ID: 7879115
    [No Abstract]   [Full Text] [Related]  

  • 14. Administration of L-GN-monomethyl-arginine in a mouse islet transplant model.
    Stevens RB; Ansite JD; Lokeh A; Saxena M; Mills CD; Sutherland DE
    Transplant Proc; 1994 Dec; 26(6):3363. PubMed ID: 7998175
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistence of tumor necrosis factor production in long-surviving concordant cardiac xenografts.
    Peterson SM; Noble BK; Gorfien J; Hoover EL; Bergsland J
    Transplant Proc; 1994 Jun; 26(3):1342-3. PubMed ID: 8029933
    [No Abstract]   [Full Text] [Related]  

  • 16. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
    Nicolae M; Ketchum RJ; Jahr H; Janoff H; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of host genetic background and microencapsulation on survival of rat-to-mouse islet xenografts.
    Weber C; Tanna A; Costanzo M; Ayres-Price J; Peterson L; Wicker L
    Transplant Proc; 1994 Jun; 26(3):1186-8. PubMed ID: 8029880
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral reaction to microencapsulated rat, canine, and porcine islet xenografts in spontaneously diabetic NOD mice.
    Weber C; D'Agati V; Ward L; Costanzo M; Rajotte R; Reemtsma K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):462-3. PubMed ID: 8438379
    [No Abstract]   [Full Text] [Related]  

  • 19. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental and clinical experience with xenoislet transplantation.
    Groth CG; Tibell A; Wennberg L; Korsgren O
    Transplant Proc; 1996 Dec; 28(6):3515. PubMed ID: 8962366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.